Home Axonics

Axonics

acquired
Seasoned Equity Offering
Developer of Novel Implantable Neuromodulation Technologies

Basic Information

Axonics is a company dedicated to developing novel implantable neuromodulation technologies. This novel implantable neuromodulation technology, licensed from The Alfred Mann Foundation, targets numerous clinical indications, including the treatment of chronic pain and overactive bladder.
Axonics, Inc.
California,United States of America
101~500 people
January 01, 2012
--